# Professor Aswath Damodaran's research on pharmaceutical companies' profit margins is cited

1 Faculty News June 22, 2019 ![The Economist logo](/sites/default/files/styles/246w/public/assets/images/uat_025662.jpg?itok=1_MW1PTy)>

Excerpt from [The Economist](https://www.economist.com/business/2019/06/22/american-drugmakers-are-raising-prices-again) -- "According to a recent study by Aswath Damodaran of New York University’s Stern School of Business, on this basis drug firms’ margins are 24%, higher than most other sectors (see chart)."

[Read more](https://www.economist.com/business/2019/06/22/american-drugmakers-are-raising-prices-again)